A case of anti-aminoacyl tRNA synthetase antibody syndrome complicated by hemophagocytic syndrome. 2016

Kota Azuma, and Masao Tamura, and Masafumi Kurajoh, and Yuji Hosono, and Ran Nakajima, and Kazuyuki Tsuboi, and Takeo Abe, and Chie Ogita, and Yuichi Yokoyama, and Tetsuya Furukawa, and Takahiro Yoshikawa, and Atsushi Saito, and Aki Nishioka, and Masahiro Sekiguchi, and Naoto Azuma, and Masayasu Kitano, and Shinichiro Tsunoda, and Koichiro Omura, and Hidenori Koyama, and Kiyoshi Matsui, and Tsuneyo Mimori, and Hajime Sano
Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine.

A 48-year-old woman had suffered from a fever and general fatigue, and visited the other hospital for fever elevation in November 2013, at which time interstitial lung disease was revealed. In January 2014, she experienced an eruption in the hand and developed peripheral blood flow damage. Under a diagnosis of adult Still's disease, the patient was administered 0.5 mg of betamethasone as well as cyclosporin at 75 mg/day. In November 2014, general fatigue, fever, and headache were noted, while MRI revealed an enlarged hypophysis and laboratory findings were positive for the anti-pituitary cell antibody, thus a diagnosis of autoimmune hypophysitis was made. Although disease activity was low, she requested hospitalization and was admitted by the Division of Endocrinology and Metabolism at our hospital in May 2015, though only observed. Fever developed again, along with interstitial lung disease, Raynaud's phenomenon, and pain in the crural area again, and we considered the possibility of another disease. After stopping administration of betamethasone and cyclosporin, we made a diagnosis of anti-aminoacyl tRNA synthetase antibody syndrome, and administered methylprednisolone at 500 mg for 3 days as well as prednisolone at 35 mg/day following steroid pulse therapy. Although her condition soon improved, fever, muscle pain, and pancytopenia returned after 3 days. Bone marrow findings revealed the existence of hemophagocytosis, for which we again gave methylprednisolone at 500 mg for 3 days and cyclosporin at 125 mg/day. Thereafter, the patient recovered and was discharged from the hospital.

UI MeSH Term Description Entries
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000604 Amino Acyl-tRNA Synthetases A subclass of enzymes that aminoacylate AMINO ACID-SPECIFIC TRANSFER RNA with their corresponding AMINO ACIDS. Amino Acyl T RNA Synthetases,Amino Acyl-tRNA Ligases,Aminoacyl Transfer RNA Synthetase,Aminoacyl-tRNA Synthetase,Transfer RNA Synthetase,tRNA Synthetase,Acyl-tRNA Ligases, Amino,Acyl-tRNA Synthetases, Amino,Amino Acyl tRNA Ligases,Amino Acyl tRNA Synthetases,Aminoacyl tRNA Synthetase,Ligases, Amino Acyl-tRNA,RNA Synthetase, Transfer,Synthetase, Aminoacyl-tRNA,Synthetase, Transfer RNA,Synthetase, tRNA,Synthetases, Amino Acyl-tRNA
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes

Related Publications

Kota Azuma, and Masao Tamura, and Masafumi Kurajoh, and Yuji Hosono, and Ran Nakajima, and Kazuyuki Tsuboi, and Takeo Abe, and Chie Ogita, and Yuichi Yokoyama, and Tetsuya Furukawa, and Takahiro Yoshikawa, and Atsushi Saito, and Aki Nishioka, and Masahiro Sekiguchi, and Naoto Azuma, and Masayasu Kitano, and Shinichiro Tsunoda, and Koichiro Omura, and Hidenori Koyama, and Kiyoshi Matsui, and Tsuneyo Mimori, and Hajime Sano
April 2018, Brain and nerve = Shinkei kenkyu no shinpo,
Kota Azuma, and Masao Tamura, and Masafumi Kurajoh, and Yuji Hosono, and Ran Nakajima, and Kazuyuki Tsuboi, and Takeo Abe, and Chie Ogita, and Yuichi Yokoyama, and Tetsuya Furukawa, and Takahiro Yoshikawa, and Atsushi Saito, and Aki Nishioka, and Masahiro Sekiguchi, and Naoto Azuma, and Masayasu Kitano, and Shinichiro Tsunoda, and Koichiro Omura, and Hidenori Koyama, and Kiyoshi Matsui, and Tsuneyo Mimori, and Hajime Sano
June 2018, QJM : monthly journal of the Association of Physicians,
Kota Azuma, and Masao Tamura, and Masafumi Kurajoh, and Yuji Hosono, and Ran Nakajima, and Kazuyuki Tsuboi, and Takeo Abe, and Chie Ogita, and Yuichi Yokoyama, and Tetsuya Furukawa, and Takahiro Yoshikawa, and Atsushi Saito, and Aki Nishioka, and Masahiro Sekiguchi, and Naoto Azuma, and Masayasu Kitano, and Shinichiro Tsunoda, and Koichiro Omura, and Hidenori Koyama, and Kiyoshi Matsui, and Tsuneyo Mimori, and Hajime Sano
March 2023, Trends in biochemical sciences,
Kota Azuma, and Masao Tamura, and Masafumi Kurajoh, and Yuji Hosono, and Ran Nakajima, and Kazuyuki Tsuboi, and Takeo Abe, and Chie Ogita, and Yuichi Yokoyama, and Tetsuya Furukawa, and Takahiro Yoshikawa, and Atsushi Saito, and Aki Nishioka, and Masahiro Sekiguchi, and Naoto Azuma, and Masayasu Kitano, and Shinichiro Tsunoda, and Koichiro Omura, and Hidenori Koyama, and Kiyoshi Matsui, and Tsuneyo Mimori, and Hajime Sano
January 2022, Frontiers in immunology,
Kota Azuma, and Masao Tamura, and Masafumi Kurajoh, and Yuji Hosono, and Ran Nakajima, and Kazuyuki Tsuboi, and Takeo Abe, and Chie Ogita, and Yuichi Yokoyama, and Tetsuya Furukawa, and Takahiro Yoshikawa, and Atsushi Saito, and Aki Nishioka, and Masahiro Sekiguchi, and Naoto Azuma, and Masayasu Kitano, and Shinichiro Tsunoda, and Koichiro Omura, and Hidenori Koyama, and Kiyoshi Matsui, and Tsuneyo Mimori, and Hajime Sano
January 2020, Scandinavian journal of rheumatology,
Kota Azuma, and Masao Tamura, and Masafumi Kurajoh, and Yuji Hosono, and Ran Nakajima, and Kazuyuki Tsuboi, and Takeo Abe, and Chie Ogita, and Yuichi Yokoyama, and Tetsuya Furukawa, and Takahiro Yoshikawa, and Atsushi Saito, and Aki Nishioka, and Masahiro Sekiguchi, and Naoto Azuma, and Masayasu Kitano, and Shinichiro Tsunoda, and Koichiro Omura, and Hidenori Koyama, and Kiyoshi Matsui, and Tsuneyo Mimori, and Hajime Sano
February 1990, Nihon rinsho. Japanese journal of clinical medicine,
Kota Azuma, and Masao Tamura, and Masafumi Kurajoh, and Yuji Hosono, and Ran Nakajima, and Kazuyuki Tsuboi, and Takeo Abe, and Chie Ogita, and Yuichi Yokoyama, and Tetsuya Furukawa, and Takahiro Yoshikawa, and Atsushi Saito, and Aki Nishioka, and Masahiro Sekiguchi, and Naoto Azuma, and Masayasu Kitano, and Shinichiro Tsunoda, and Koichiro Omura, and Hidenori Koyama, and Kiyoshi Matsui, and Tsuneyo Mimori, and Hajime Sano
May 1994, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Kota Azuma, and Masao Tamura, and Masafumi Kurajoh, and Yuji Hosono, and Ran Nakajima, and Kazuyuki Tsuboi, and Takeo Abe, and Chie Ogita, and Yuichi Yokoyama, and Tetsuya Furukawa, and Takahiro Yoshikawa, and Atsushi Saito, and Aki Nishioka, and Masahiro Sekiguchi, and Naoto Azuma, and Masayasu Kitano, and Shinichiro Tsunoda, and Koichiro Omura, and Hidenori Koyama, and Kiyoshi Matsui, and Tsuneyo Mimori, and Hajime Sano
December 2022, Autoimmunity reviews,
Kota Azuma, and Masao Tamura, and Masafumi Kurajoh, and Yuji Hosono, and Ran Nakajima, and Kazuyuki Tsuboi, and Takeo Abe, and Chie Ogita, and Yuichi Yokoyama, and Tetsuya Furukawa, and Takahiro Yoshikawa, and Atsushi Saito, and Aki Nishioka, and Masahiro Sekiguchi, and Naoto Azuma, and Masayasu Kitano, and Shinichiro Tsunoda, and Koichiro Omura, and Hidenori Koyama, and Kiyoshi Matsui, and Tsuneyo Mimori, and Hajime Sano
January 2021, Modern rheumatology case reports,
Kota Azuma, and Masao Tamura, and Masafumi Kurajoh, and Yuji Hosono, and Ran Nakajima, and Kazuyuki Tsuboi, and Takeo Abe, and Chie Ogita, and Yuichi Yokoyama, and Tetsuya Furukawa, and Takahiro Yoshikawa, and Atsushi Saito, and Aki Nishioka, and Masahiro Sekiguchi, and Naoto Azuma, and Masayasu Kitano, and Shinichiro Tsunoda, and Koichiro Omura, and Hidenori Koyama, and Kiyoshi Matsui, and Tsuneyo Mimori, and Hajime Sano
June 2005, The Journal of biological chemistry,
Copied contents to your clipboard!